ArticleFrontiers in genetics2022

An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers.

Chungen Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.